A jury awarded $6 million in damages to scientist David Sabatini, whose career imploded after he was accused by a much younger colleague of inappropriate sexual conduct in his lab.

Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA ...

Changes to the annual performance review process are the latest flashpoint in tensions between federal workers across the ...

As I prepared for my appointment, the hospital asked me to sign its registration forms and to sign up for MyChart. In the ...

Ahead of "You Can See Everything" hitting theaters, let's rewind the last decade and review some of the most significant news ...

Bipartisan legislation under review in Congress has the potential to significantly rejigger global drug development — and the biggest beneficiaries may not be American. The bill, titled the Biotech ...

Whoop's chief medical officer, said the company's work with Medicare is an opportunity to prove its ability to improve health ...

At the STAT Summit, the Department of Justice offered up a warning for health care executives: Don’t be another Theranos.

The CEO of Compass Pathways said the company, whose psychedelic therapy is set for regulatory review this year, is prepared ...

Following a green light from the FDA, European regulators have now recommended the approval of Revolution Medicines' Rasonque for pancreatic cancer.

The legal and medical issues in the Christa Pike case are on a collision course,” writes bioethicist M. Sara Rosenthal.

The XBI is still up 24%, although it’s down 11% from the August high. The retreat doesn’t look that alarming relative to the ...